Translational and clinical implications of the genetic landscape of prostate cancer

Por Spratt, Daniel E., Zumsteg, Zachary S., Feng, Felix Y., Tomlins, Scott A.
Publicado no Nat Rev Clin Oncol (2016)

Metformin and Prostate Cancer: Benefit for Development of Castration-resistant Disease and Prostate Cancer Mortality

Por Spratt, Daniel E., Zhang, Chi, Zumsteg, Zachary S., Pei, Xin, Zhang, Zhigang, Zelefsky, Michael J.
Publicado em 2012

Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatment

Por Castel, Pau, Toska, Eneda, Zumsteg, Zachary S, Carmona, F Javier, Elkabets, Moshe, Bosch, Ana, Scaltriti, Maurizio
Publicado no Mol Cell Oncol (2014)

The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study

Por Spratt, Daniel E., Beadle, Beth M., Zumsteg, Zachary S., Rivera, Andrew, Skinner, Heath D., Osborne, Joseph R., Garden, Adam S., Lee, Nancy Y.
Publicado no Int J Radiat Oncol Biol Phys (2015)

Anatomic Patterns of Recurrence Following Biochemical Relapse in the Dose-Escalation Era for Prostate Patients Undergoing External Beam Radiotherapy

Por Zumsteg, Zachary S., Spratt, Daniel E., Romesser, Paul B., Pei, Xin, Zhang, Zhigang, Kollmeier, Marisa, McBride, Sean, Yamada, Yoshiya, Zelefsky, Michael J.
Publicado no J Urol (2015)

AI-09 PATTERNS OF SALVAGE TREATMENT FOR HIGH GRADE GLIOMA IN THE TEMOZOLOMIDE ERA

Por Escorcia, Freddy E., Folkert, Michael R., Spratt, Daniel E., Zumsteg, Zachary, Chan, Timothy, Omuro, Antonio M., Beal, Kathryn, Gutin, Philip H., Yamada, Josh
Publicado em 2014

The Natural History and Predictors of Outcome Following Biochemical Relapse in the Dose Escalation Era for Prostate Cancer Patients Undergoing Definitive External Beam Radiotherapy

Por Zumsteg, Zachary S., Spratt, Daniel E., Romesser, Paul B., Pei, Xin, Zhang, Zhigang, Polkinghorn, William, McBride, Sean, Kollmeier, Marisa, Yamada, Yoshiya, Zelefsky, Michael J.
Publicado no Eur Urol (2014)

Impact of flap reconstruction on radiotoxicity after salvage surgery and reirradiation for recurrent head and neck cancer

Por Ho, Allen S., Zumsteg, Zachary S., Meyer, Annika, Riaz, Nadeem, Rahmati, Rahmatullah, Kraus, Dennis H., McCarthy, Colleen, Wong, Richard J., Shah, Jatin P., Lee, Nancy Y.
Publicado no Ann Surg Oncol (2016)

Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations

Por Zumsteg, Zachary S., Morse, Natasha, Krigsfeld, Gabriel, Gupta, Gaorav, Higginson, Daniel S., Lee, Nancy Y., Morris, Luc, Ganly, Ian, Shiao, Stephan L., Powell, Simon N., Chung, Christine H., Scaltriti, Maurizio, Baselga, José
Publicado no Clin Cancer Res (2015)

The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 and older with oropharyngeal carcinoma in the intensity modulated radiotherapy era

Por Zumsteg, Zachary S., Lok, Benjamin H., Ho, Allen S., Drill, Esther, Zhang, Zhigang, Riaz, Nadeem, Shiao, Stephen L., Ma, Jennifer, McBride, Sean M., Tsai, C. Jillian, Baxi, Shrujal S., Sherman, Eric J., Lee, Nancy Y.
Publicado no Cancer (2016)